NCT00398541View on ClinicalTrials.gov

Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)

PHASE3CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 1, 2005

Primary Completion Date

April 10, 2007

Study Completion Date

June 1, 2007

Conditions
Hypertension
Interventions
DRUG

losartan potassium (+) hydrochlorothiazide

losartan potassium (+) hydrochlorothiazide combination will be titrated upwards according to the following scheme: losartan potassium 50/hydrochlorothiazide 12.5 then losartan potassium 100/hydrochlorothiazide 12.5 then losartan potassium 100/hydrochlorothiazide 25

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00398541 - Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322) | Biotech Hunter | Biotech Hunter